Wexford Capital’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-77,879
| Closed | -$77.9K | – | 297 |
|
|
2025
Q1 | $77.9K | Sell |
77,879
-174,243
| -69% | -$174K | 0.02% | 208 |
|
|
2024
Q4 | $2.67M | Buy |
252,122
+34,243
| +16% | +$363K | 0.43% | 36 |
|
|
2024
Q3 | $2.88M | Buy |
217,879
+103,285
| +90% | +$1.36M | 0.69% | 42 |
|
|
2024
Q2 | $1.13M | Buy |
114,594
+85,421
| +293% | +$840K | 0.29% | 56 |
|
|
2024
Q1 | $401K | Buy |
+29,173
| New | +$401K | 0.08% | 146 |
|